Daniel Beriault, University of Toronto

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Validation and generation of age-specific reference intervals for a new blood neurofilament light chain assay.
Clinica chimica acta; international journal of clinical chemistry · 2025
‘Raise the Bar’, a Canadian intervention to combat disparities in the recognition and management of iron deficiency: Development of the intervention, feasibility and implementation
British Journal of Haematology · 2025
The origin of ferritin reference intervals: a systematic review.
The Lancet. Haematology · 2024

All 9 publications

Latest funding

Development and validation of a novel point-of-care technology for rapid non-targeted identification of emerging threats in North American drug markets
CIHR · 2025 · Co-investigator
$1,453,500
Rapidly assessing the impact of the COVID-19 pandemic and response on clinical and social outcomes, service utilization, and the unregulated drug supply experienced by people who use drugs in Toronto
CIHR · 2020 · Co-investigator
$206,760

All 2 grants and awards

9 publications.

01

Validation and generation of age-specific reference intervals for a new blood neurofilament light chain assay.

Booth RA, Beriault D, Schneider R, Benkert P, Willemse EAJ, Maceski AM, Leppert D, Freedman MS, Kuhle J

Clinica chimica acta; international journal of clinical chemistry2025

DOI: 10.1016/j.cca.2025.120447 PMID: 40562335

02

‘Raise the Bar’, a Canadian intervention to combat disparities in the recognition and management of iron deficiency: Development of the intervention, feasibility and implementation

Tang GH, Phillips Z, Poutanen S, Yip P, Brinc D, Goh E, Cheung M, Pai M, Oleschuk C, Beriault D

British Journal of Haematology20256 citations

DOI: 10.1111/bjh.70150

03

The origin of ferritin reference intervals: a systematic review.

Truong J, Naveed K, Beriault D, Lightfoot D, Fralick M, Sholzberg M

The Lancet. Haematology2024

DOI: 10.1016/s2352-3026(24)00103-0 PMID: 38937026

04

Imprecision of high-sensitivity cardiac troponin assays at the female 99th-percentile

Kavsak PA, Clark L, Arnoldo S, Lou A, Shea JL, Eintracht S, Lyon AW, Bhayana V, Thorlacius L, Raizman JE

Clinical Biochemistry202410 citations

DOI: 10.1016/j.clinbiochem.2024.110731

05

Defining ferritin clinical decision limits to improve diagnosis and treatment of iron deficiency: A modified Delphi study

Naveed K, Goldberg N, Shore E, Dhoot A, Gabrielson D, Goodarzi Z, Lin Y, Pai M, Pardy NA, Robinson S

International Journal of Laboratory Hematology202333 citations

DOI: 10.1111/ijlh.14016

06

Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings.

Ti L, Tobias S, Maghsoudi N, Milloy MJ, McDonald K, Shapiro A, Beriault D, Stefan C, Lysyshyn M, Werb D

Drug and alcohol review2021

DOI: 10.1111/dar.13237 PMID: 33354869

07

Implementing effective test utilization via team-based evaluation and revision of a family medicine laboratory test requisition.

Mohammed-Ali Z, Bhandarkar S, Tahir S, Handford C, Yip D, Beriault D, Hicks LK

BMJ open quality2021

DOI: 10.1136/bmjoq-2020-001219 PMID: 33731485

08

DAMPAned Methotrexate: A Case Report and Review of the Management of Acute Methotrexate Toxicity.

Young A, Beriault D, Jung B, Nikonova A, Abosh D, Lee S, Zaltzman J, Perl J

Canadian journal of kidney health and disease2019

DOI: 10.1177/2054358119895078 PMID: 31903191

09

The Role of Procalcitonin in Diagnosis of Sepsis and Antibiotic Stewardship: Opportunities and Challenges

Fung AW, Beriault D, Diamandis EP, Burnham C-AD, Dorman T, Downing M, Hayden J, Langford BJ

Clinical Chemistry201717 citations

DOI: 10.1373/clinchem.2017.272294

Development and validation of a novel point-of-care technology for rapid non-targeted identification of emerging threats in North American drug markets

Co-investigatorCIHR2025Project Grant

Principal investigators: Werb, Daniel M

Keywords: Differential Pulse Voltammetry; Drug Checking Services; Harm Reduction; Machine Learning; Overdose Prevention

$1,453,500

Rapidly assessing the impact of the COVID-19 pandemic and response on clinical and social outcomes, service utilization, and the unregulated drug supply experienced by people who use drugs in Toronto

Co-investigatorCIHR2020Op Grant: COVID-19 Rapid Research FO - Social Policy and Public Health Responses

Principal investigators: Werb, Daniel M; Caudarella, Alexander; Bayoumi, Ahmed M; Bowles, Jeanette; Gomes, Tara; Kolla, Gillian; Scheim, Ayden

Keywords: Addiction Treatment; Clinical Severity; Mixed Methods; People Who Inject Drugs; Qualitative; Service Barriers; Street Drug Checking; Supervised Injection Services

$206,760

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Applying for

Paper to mention

Subject: Prospective PhD student Dear Professor Beriault, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Validation and generation of age-specific reference intervals for a new blood neurofilament light chain assay." (2025), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Daniel Beriault

Research

Latest papers

Latest funding

Validation and generation of age-specific reference intervals for a new blood neurofilament light chain assay.

‘Raise the Bar’, a Canadian intervention to combat disparities in the recognition and management of iron deficiency: Development of the intervention, feasibility and implementation

The origin of ferritin reference intervals: a systematic review.

Imprecision of high-sensitivity cardiac troponin assays at the female 99th-percentile

Defining ferritin clinical decision limits to improve diagnosis and treatment of iron deficiency: A modified Delphi study

Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings.

Implementing effective test utilization via team-based evaluation and revision of a family medicine laboratory test requisition.

DAMPAned Methotrexate: A Case Report and Review of the Management of Acute Methotrexate Toxicity.

The Role of Procalcitonin in Diagnosis of Sepsis and Antibiotic Stewardship: Opportunities and Challenges

Development and validation of a novel point-of-care technology for rapid non-targeted identification of emerging threats in North American drug markets

Rapidly assessing the impact of the COVID-19 pandemic and response on clinical and social outcomes, service utilization, and the unregulated drug supply experienced by people who use drugs in Toronto

Frequent collaborators

Menaka Pai

Michael Fralick

Davor Brinc

Elaine Goh

Paul Yip

Peter Kavsak

Emilie Belley-Cote

Sameer Sharif

Andrew Worster

Jeffrey Perl

Dennis Ko

Daniel Werb

Curtis Handford

Lianping Ti

Susan Poutanen

Mark Lysyshyn

Zahra Goodarzi

Jennifer Taher

Manish Sood

Venkatesh Thiruganasambandamoorthy

Frank Scheuermeyer

Mark Crowther

Raphael Schneider